Alta Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.21M | Hold |
4,119
| – | – | 1.14% | 16 |
|
|
2025
Q1 | $3.4M | Buy |
4,119
+1,500
| +57% | +$1.24M | 1.45% | 15 |
|
|
2024
Q4 | $2.02M | Buy |
2,619
+319
| +14% | +$246K | 1.28% | 15 |
|
|
2024
Q3 | $2.04M | Hold |
2,300
| – | – | 0.93% | 14 |
|
|
2024
Q2 | $2.08M | Hold |
2,300
| – | – | 1% | 11 |
|
|
2024
Q1 | $1.79M | Hold |
2,300
| – | – | 0.89% | 12 |
|
|
2023
Q4 | $1.34M | Buy |
2,300
+200
| +10% | +$117K | 0.72% | 14 |
|
|
2023
Q3 | $1.13M | Hold |
2,100
| – | – | 0.65% | 15 |
|
|
2023
Q2 | $985K | Hold |
2,100
| – | – | 0.55% | 18 |
|
|
2023
Q1 | $721K | Hold |
2,100
| – | – | 0.43% | 23 |
|
|
2022
Q4 | $768K | Hold |
2,100
| – | – | 0.46% | 21 |
|
|
2022
Q3 | $679K | Buy |
+2,100
| New | +$679K | 0.43% | 21 |
|